Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

Importance Many patients with systemic amyloidosis are underdiagnosed. Overall, 25% of
patients with immunoglobulin light chain (AL) amyloidosis die within 6 months of diagnosis …

Aims The study aims to systematically assess the diagnostic performance of cardiac
magnetic resonance (CMR) and nuclear scintigraphy (index tests) for the diagnosis and …

Purpose Cardiac transthyretin-related amyloidosis (ATTR) is a progressive and fatal
cardiomyopathy. The diagnosis of this disease is frequently delayed or missed due to the …

Background Bone tracers bind to amyloid-containing heart of most patients with ATTR
amyloidosis. Amyloid deposits outside the heart are often scarce and bone scintigraphy is …

Amyloid transthyretin (ATTR) amyloidosis is a protein-misfolding disease characterized by
fibril accumulation in the extracellular space that can result in local tissue disruption and …

Background Bone scintigraphy imaging is frequently used to investigate patients with
suspected transthyretin cardiac amyloidosis (ATTR-CM). However, the reported accuracy for …

Abstract Purpose of Review Left ventricular hypertrophy (LVH) is a common presentation
encountered in clinical practice with a diverse range of potential aetiologies. Differentiation …

Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt CM) is a more common disease
than previously thought. Awareness of ATTRwt CM and its diagnosis has been challenged …

Cardiac amyloidosis is caused by the deposition of misfolded protein fibrils into the
extracellular space of the heart. The diagnosis of cardiac amyloidosis remains challenging …